We are live on
!
Find out more
PCM
Prelude Capital Management Portfolio holdings
AUM
$1.31B
1-Year Est. Return
62.02%
This Fund
S&P 500
This Quarter
Est. Return
+11.22%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.92B
AUM Growth
-$861M
(-31%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-56.34%
Top 10 Holdings %
Top 10 Hldgs %
24.9%
Holding
1,961
New
419
Increased
272
Reduced
381
Closed
669
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KE Holdings
BEKE
|
+$13.6M |
| 2 |
TSMC
TSM
|
+$11.4M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$11.3M |
| 4 |
Applied Materials
AMAT
|
+$9.44M |
| 5 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
+$6.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KAHC
KKR Acquisition Holdings I Corp.
KAHC
|
+$30.7M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
+$30.3M |
| 3 |
Y
Alleghany Corp
Y
|
+$24.9M |
| 4 |
CTXS
Citrix Systems Inc
CTXS
|
+$17M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.05% |
| 2 | Technology | 12.34% |
| 3 | Consumer Discretionary | 8.56% |
| 4 | Industrials | 7.99% |
| 5 | Healthcare | 7.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Alto Ingredients
ALTO
$320M
| $103K | 0.01% |
35,600
+22,000
| +162% | +$78.2K |
|
|
AILE
1052
DELISTED
iLearningEngines, Inc. Common Stock
AILE
| $101K | 0.01% |
+10,040
| New | +$99.8K |
|
1053
Manitowoc
MTW
$707M
| $99.8K | 0.01% |
10,900
-1,500
| -12% | -$13.7K |
|
|
TLIS
1054
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $99.8K | 0.01% |
14,929
| – | – |
|
1055
Accel Entertainment
ACEL
$1B
| $98.9K | 0.01% |
12,845
+2,389
| +23% | +$20.5K |
|
1056
2x Long VIX Futures ETF
UVIX
$217M
| $98K | 0.01% |
+2
| New | +$183K |
|
1057
OPAL Fuels
OPAL
$80.4M
| $97.9K | 0.01% |
+13,450
| New | +$109K |
|
1058
Western New England Bancorp
WNEB
$280M
| $94.7K | ﹤0.01% |
10,015
-2,400
| -19% | -$21.9K |
|
1059
CALL
Nokia
NOK
$52.6B
| $94.7K | ﹤0.01% |
20,400
-7,400
| -27% | -$34.1K |
|
1060
Radiant Logistics
RLGT
$385M
| $93.6K | ﹤0.01% |
18,392
+4,147
| +29% | +$23.3K |
|
1061
Arbutus Biopharma
ABUS
$924M
| $93.5K | ﹤0.01% |
40,149
-13,728
| -25% | -$32.8K |
|
1062
FTAI Infrastructure
FIP
$521M
| $93.5K | ﹤0.01% |
31,681
+20,942
| +195% | +$57.9K |
|
1063
Codexis
CDXS
$159M
| $93K | ﹤0.01% |
+19,959
| New | +$109K |
|
1064
Sensus Healthcare
SRTS
$50.4M
| $92.5K | ﹤0.01% |
12,460
-21,265
| -63% | -$192K |
|
1065
Rimini Street
RMNI
$453M
| $91.8K | ﹤0.01% |
24,100
+5,000
| +26% | +$22.2K |
|
1066
QuantumScape Corp
QS
$3.9B
| $91.4K | ﹤0.01% |
+16,115
| New | +$119K |
|
1067
Telos
TLS
$317M
| $90.5K | ﹤0.01% |
+17,788
| New | +$118K |
|
1068
Oric Pharmaceuticals
ORIC
$1.44B
| $90.4K | ﹤0.01% |
15,353
+143
| +0.9% | +$483 |
|
1069
CALL
Lucid Motors
LCID
$2.62B
| $89.5K | ﹤0.01% |
1,310
-280
| -18% | -$30.8K |
|
|
BRSP
1070
BrightSpire Capital
BRSP
$626M
| $89.2K | ﹤0.01% |
14,316
+3,705
| +35% | +$25.7K |
|
1071
Cellebrite
CLBT
$4.09B
| $88.7K | ﹤0.01% |
+20,349
| New | +$90.9K |
|
|
CANO
1072
DELISTED
Cano Health, Inc.
CANO
| $88K | ﹤0.01% |
643
+361
| +128% | +$122K |
|
|
KBAL
1073
DELISTED
Kimball International
KBAL
| $87.8K | ﹤0.01% |
+13,500
| New | +$92.3K |
|
|
SOS
1074
CALL
SOS Limited
SOS
$14.1M
| $87.6K | ﹤0.01% |
2,140
| – | – |
|
|
DCH
1075
Dauch Corp
DCH
$1.64B
| $87.6K | ﹤0.01% |
+11,206
| New | +$100K |
|
Similar funds
PFBT
SP
HCS
SPC
GPCM
MCM
CC
MB
Prelude Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Prelude Capital Management held 1,961 positions worth $1.92B, down 31% from $2.79B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Prelude Capital Management withdrew a net $1.08B in Q4 2022, closing 669 positions and reducing 381 holdings. Its most notable exit was KKR Acquisition Holdings I Corp., an estimated $30.7M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Prelude Capital Management opened a new position in AVEO Pharmaceuticals, Inc. worth $7.55M.
- Prelude Capital Management's largest Q4 2022 buy was AVEO Pharmaceuticals, Inc.: 504,972 shares worth $7.55M.
- Prelude Capital Management added most to KE Holdings in Q4 2022, an estimated $13.6M increase.
- Prelude Capital Management's biggest Q4 2022 reduction was Alphabet (Google) Class A, cutting an estimated $6.9M.
- Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. in Q4 2022, selling an estimated $30.7M.
- Prelude Capital Management's ten largest holdings make up 25% of its $1.92B portfolio in Q4 2022.
- Prelude Capital Management opened 419 new positions and closed 669 in Q4 2022.
- Prelude Capital Management's portfolio value fell 31% quarter-over-quarter to $1.92B.
Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.